Article
Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association.
Circulation - 7 Jul 2020
Kittleson Michelle M, Maurer Mathew S, Ambardekar Amrut V, Bullock-Palmer Renee P, Chang Patricia P, Eisen Howard J, Nair Ajith P, Nativi-Nicolau Jose, Ruberg Frederick L
Abstract excerpt
Transthyretin amyloid cardiomyopathy (ATTR-CM) results in a restrictive cardiomyopathy caused by extracellular deposition of transthyretin, normally involved in the transportation of the hormone thyroxine and retinol-binding protein, in the myocardium. Enthusiasm about ATTR-CM has grown as a result of 3 simultaneous areas of advancement: Imaging techniques allow accurate noninvasive diagnosis of ATTR-CM without...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.